Waltham's Tesaro to be acquired by GlaxoSmithKline for $5.1B
December 03, 2018 at 09:54 AM EST
Drug giant GlaxoSmithKline plc will acquire Waltham-based biotech Tesaro Inc. for $5.1 billion, the companies announced Monday morning.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.